Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Ajooni Biotech's FCF Margin % or its related term are showing as below:
NSE:AJOONI'
s FCF Margin % Range Over the Past 10 Years
Min: -29.65 Med: -8.78 Max: 21.6
Current: -20.72
During the past 13 years, the highest FCF Margin % of Ajooni Biotech was 21.60%. The lowest was -29.65%. And the median was -8.78%.
NSE:AJOONI's FCF Margin % is ranked worse than 89.56% of 1954
companies
in the Consumer Packaged Goods industry
Industry Median: 1.95
vs NSE:AJOONI: -20.72
The historical data trend for Ajooni Biotech's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Ajooni Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ajooni Biotech FCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Ajooni Biotech's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ajooni Biotech's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ajooni Biotech (NSE:AJOONI) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ajooni Biotech and its competitors. According to the industry distribution chart, Ajooni Biotech ranks #1750 out of 1954 companies in the Consumer Packaged Goods industry, placing it in the top 89.6%.
Is Ajooni Biotech's FCF Margin % too high?
Ajooni Biotech's current FCF Margin % is 0.00%. Based on the distribution chart, Ajooni Biotech ranks #1750 out of 1954 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Ajooni Biotech has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ajooni Biotech's FCF Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Ajooni Biotech ranks #1750 out of 1954 companies for FCF Margin %. This places Ajooni Biotech in the lower half of its industry. The industry median FCF Margin % is 1.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Consumer Packaged Goods company?
The median FCF Margin % among Consumer Packaged Goods companies is 1.95, based on 1,954 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ajooni Biotech and its competitors. For the Consumer Packaged Goods industry, the median FCF Margin % is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ajooni Biotech's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajooni Biotech stock overvalued right now?
Based on GuruFocus' analysis, Ajooni Biotech (NSE:AJOONI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹6.26, compared to a current price of ₹3.86 — trading 38.3% below its estimated fair value. The current FCF Margin % is 0.00%. Ajooni Biotech's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ajooni Biotech (NSE:AJOONI), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ajooni Biotech (NSE:AJOONI) Overvalued in 2026?
Based on GuruFocus' analysis, Ajooni Biotech stock appears to be undervalued.
The current stock price of ₹3.86 is trading 38.3% below its estimated GF Value™ of ₹6.26.
GuruFocus considers Ajooni Biotech to be Possible Value Trap.
Key valuation signals for NSE:AJOONI:
FCF Margin %: 0.00%
GF Value™: ₹6.26 vs. price of ₹3.86 (38.3% below fair value)
No single metric tells the full story. See the NSE:AJOONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ajooni Biotech Ltd is engaged in providing animal health care solutions dedicated to improving the productivity of Dairy farmers and sustainably increasing livestock yields. The company's products of cattle feed include Gold Pashu Aahar, Buff Plus, 3 Star, 4 Star, Calf Starter, & Transition Plus, and its feed supplements include Calvit, Batisa, Liv, Min, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.
64GF Score
Get the complete analysis for NSE:AJOONI
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AJOONI has been successfully added to your 
